In Re: Ozempic (Semaglutide) Patent Litigation
Not Classified By Court: Zydus Lifesciences Limited, Ozempic (Semaglutide) Patent Litigation, Novo Nordisk Inc., Novo Nordisk A/S, Rio Biopharmaceuticals, Inc., EMS S/A, Sun Pharmaceutical Industries Ltd., Sun Pharmaceuticals Industries Inc., Clerk of MDL Panel, Zydus Worldwide DMCC, Zydus Pharmaceuticals (USA) Inc., Cadila Healthcare Ltd., Dr. Reddy's Laboratories Ltd., Dr. Reddy's Laboratories Inc., Alvogen, Inc. and Mylan Pharmaceuticals Inc.
Case Number: 1:2022md03038
Filed: August 5, 2022
Court: US District Court for the District of Delaware
Presiding Judge: Colm F Connolly
Nature of Suit: Patent - Abbreviated New Drug Application(ANDA)
Cause of Action: 35 U.S.C. § 271 Patent Infringement
Jury Demanded By: None
RSS RSS Track this Docket
Docket Report

This docket was last retrieved on May 11, 2023. A more recent docket listing may be available from PACER.

Date Filed Document Text
May 11, 2023 Opinion or Order Filing 127 [SEALED] SO ORDERED, re (125 in 1:22-md-03038-CFC, 139 in 1:22-cv-00294-CFC) Stipulation of Dismissal As To Dr. Reddy's Laboratories, Ltd. And Dr. Reddy's Laboratories, Inc. Regarding The '154, '239, '611, '155, '063, And '363 Patents, filed by Novo Nordisk A/S, Novo Nordisk Inc. Signed by Judge Colm F. Connolly on 5/11/2023.This order has been emailed to local counsel. Associated Cases: 1:22-md-03038-CFC, 1:22-cv-00294-CFC(kmd)
May 10, 2023 Filing 126 OBJECTIONS by Novo Nordisk A/S, Novo Nordisk Inc. to (89 in 1:22-cv-01040-CFC, 89 in 1:22-cv-01040-CFC) Answer to Amended Complaint, Counterclaim // Plaintiffs' Answer to Mylan Pharmaceuticals Inc.'s Counterclaims to First Amended Complaint. (Murray, Travis)
May 10, 2023 Filing 125 [SEALED] STIPULATION of Dismissal As To Dr. Reddy's Laboratories, Ltd. And Dr. Reddy's Laboratories, Inc. Regarding The '154, '239, '611, '155, '063, And '363 Patents by Novo Nordisk A/S, Novo Nordisk Inc.. (Murray, Travis)
May 8, 2023 Filing 124 REDACTED VERSION of (137 in 1:22-cv-00294-CFC, 123 in 1:22-md-03038-CFC, 95 in 1:22-cv-01040-CFC) Appendix, by Novo Nordisk A/S, Novo Nordisk Inc.. (Attachments: #1 Exs. A-L, #2 Exs. 1-14)(Murray, Travis)
May 5, 2023 Filing 123 [SEALED] Joint APPENDIX re (119 in 1:22-md-03038-CFC) Joint Claim Construction Brief, (91 in 1:22-cv-01040-CFC) Joint Claim Construction Brief, (136 in 1:22-cv-00294-CFC) Joint Claim Construction Brief - by Novo Nordisk A/S, Novo Nordisk Inc.. (Attachments: #1 Exs. A-L, #2 Exs. 1-14)(Murray, Travis)
May 5, 2023 CORRECTING ENTRY: The Sealed Joint Appendix to the Joint Claim Construction Brief has been deleted as Exhibit K was blurry and difficult to read. A corrected version will be filed soon. Associated Cases: 1:22-md-03038-CFC, 1:22-cv-00294-CFC, 1:22-cv-01040-CFC(nmf)
May 2, 2023 Opinion or Order Filing 122 SO ORDERED, re (93 in 1:22-cv-01040-CFC, 121 in 1:22-md-03038-CFC) STIPULATION TO EXTEND TIME for Novo Nordisk Inc. and Novo Nordisk A/S to respond to Mylan Pharmaceuticals Inc.'s Answer, Separate Defenses, and Counterclaims to First Amended Complaint to May 10, 2023, filed by Novo Nordisk A/S, Novo Nordisk Inc. Signed by Judge Colm F. Connolly on 5/2/2023. Associated Cases: 1:22-md-03038-CFC, 1:22-cv-01040-CFC(kmd)
May 2, 2023 Filing 121 STIPULATION TO EXTEND TIME for Novo Nordisk Inc. and Novo Nordisk A/S to respond to Mylan Pharmaceuticals Inc.'s Answer, Separate Defenses, and Counterclaims to First Amended Complaint to May 10, 2023 - filed by Novo Nordisk A/S, Novo Nordisk Inc.. (Murray, Travis)
May 1, 2023 Filing 119 JOINT CLAIM CONSTRUCTION BRIEF - filed by Novo Nordisk Inc., Novo Nordisk A/S. (Murray, Travis)
April 27, 2023 Filing 118 NOTICE OF SERVICE of Defendants' Sur-Reply Claim Construction Brief filed by Mylan Pharmaceuticals Inc..(Stamoulis, Stamatios)
April 25, 2023 Filing 117 NOTICE OF SERVICE of Alvogen, Inc.'s First Amended and Supplemental Disclosures Pursuant to Paragraph 3 of the Default Standard for Discovery filed by Alvogen, Inc..(DiBenedetto, Emily)
April 12, 2023 Filing 116 ANSWER to Amended Complaint, re: #111 Amended Complaint , COUNTERCLAIM against Novo Nordisk A/S, Novo Nordisk Inc. by Mylan Pharmaceuticals Inc..(Stamoulis, Stamatios)
April 6, 2023 Filing 115 NOTICE OF SERVICE of (1) Novo Nordisk's Reply Claim Construction Brief and (2) Declaration of Laura T. Moran in Support of Novo Nordisk A/S and Novo Nordisk Inc.'s Reply Claim Construction Brief - filed by Novo Nordisk A/S, Novo Nordisk Inc..(Murray, Travis)
April 4, 2023 Filing 114 STIPULATION TO EXTEND TIME to Respond to Amended Complaint to April 12, 2023 - filed by Mylan Pharmaceuticals Inc.. (Stamoulis, Stamatios)
April 4, 2023 Opinion or Order SO ORDERED, re #114 STIPULATION TO EXTEND TIME to Respond to Amended Complaint to April 12, 2023 filed by Mylan Pharmaceuticals Inc. Reset Answer Deadlines: Mylan Pharmaceuticals Inc. answer due 4/12/2023. Ordered by Judge Colm F. Connolly on 4/4/2023. (kmd)
March 22, 2023 Filing 113 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,114,833; 8,129,343; 8,536,122; ;8,684,969; 8,920,383; 9,108,002; ;9,132,239; 9,457,154; 9,616,180; ;9,687,611; 9,775,953; 9,861,757; ;10,220,155; 10,335,462; 10,357,616; ;10,376,652; 11,097,063; 11,311,679; ;11,446,443; and RE46,363 . (Murray, Travis)
March 22, 2023 Filing 112 Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: No earlier than February 13, 2023 (as to Mylan Pharmaceuticals, Inc.'s ANDA No. 217706 added to the case in Plaintiffs' First Amended Complaint). Date of Expiration of Patent: U.S. Patent No. 8,114,833 expires on 8/13/2025; U.S. Patent Nos. 8,684,969 and 11,446,443 expire on 10/20/2025; U.S. Patent Nos. 9,108,002, 9,616,180, 9,861,757, 10,357,616, 10,376,652, and 11,311,679 expire on 1/20/2026; U.S. Patent No. 8,536,122 expires on 3/20/2026; Patent No. RE46,363 expires on 8/3/2026; U.S. Patent No. 9,687,611 expires on 2/27/2027; U.S. Patent Nos. 8,920,383, 9,775,953, 10,220,155, and 11,097,063 expire on 7/17/2026; U.S. Patent No. 9,457,154 expires on 9/27/2027; U.S. Patent No. 9,132,239 expires on 2/1/2032; U.S. Patent No. 8,129,343 expires on 12/5/2031.Thirty Month Stay Deadline: 8/13/2025. (Murray, Travis)
March 21, 2023 PATENT REPORT NOTICE: Please note that if patents are being added to this case, the filing party should complete the Report to Commissioner of Patents & Trademarks, and enter it on the docket using the PATENT/TRADEMARK REPORT event in the OTHER DOCUMENT list. The patent report form can be found at www.ded.uscourts.gov under the Clerk's Office FORMS button. (nmf)
March 21, 2023 Filing 111 FIRST AMENDED COMPLAINT against Mylan Pharmaceuticals Inc.- filed by Novo Nordisk Inc., Novo Nordisk A/S. (Attachments: #1 Exhibit A)(kmd)
March 21, 2023 Opinion or Order Filing 110 SO ORDERED, re (82 in 1:22-cv-01040-CFC, 109 in 1:22-md-03038-CFC) Stipulation to Amend Complaint, filed by Novo Nordisk A/S, Novo Nordisk Inc. Signed by Judge Colm F. Connolly on 3/21/2023. Associated Cases: 1:22-md-03038-CFC, 1:22-cv-01040-CFC(kmd)
March 21, 2023 Filing 109 STIPULATION to Amend Complaint (D.I. 2 in 1:22-cv-01040-CFC) - by Novo Nordisk A/S, Novo Nordisk Inc.. (Attachments: #1 Ex. 1 - First Amended Complaint, #2 Exs. A-T to First Amended Complaint, #3 Ex. 2 - Redline)(Murray, Travis)
March 17, 2023 Filing 108 NOTICE OF SERVICE of copies of (i) Defendants' Answering Claim Construction Brief; and, (ii) Declaration of Karl R. Leinsing, MSME, PE filed by Dr. Reddy's Laboratories Inc., Dr. Reddy's Laboratories Ltd..(Gattuso, Dominick)
March 7, 2023 Filing 107 NOTICE OF SERVICE of Plaintiffs' Second Supplemental Disclosure of Asserted Patents and Claims as to DRL Defendants filed by Novo Nordisk A/S, Novo Nordisk Inc..(Murray, Travis)
March 7, 2023 Filing 106 NOTICE OF SERVICE of Plaintiffs' Second Supplemental Disclosure of Asserted Patents and Claims as to Alvogen filed by Novo Nordisk A/S, Novo Nordisk Inc..(Murray, Travis)
March 6, 2023 Filing 105 NOTICE OF SERVICE of Plaintiffs' First Amended Infringement Contentions Regarding the '343 Patent (Individual Sets Served on Each Defendant Group) - filed by Novo Nordisk A/S, Novo Nordisk Inc..(Murray, Travis)
February 24, 2023 Filing 104 NOTICE OF SERVICE of Novo Nordisk's Opening Claim Construction Brief - filed by Novo Nordisk A/S, Novo Nordisk Inc..(Murray, Travis)
February 9, 2023 Filing 103 NOTICE OF SERVICE of Plaintiffs' First Supplemental Disclosure of Asserted Patents and Claims as to RIO Defendants, Sun Defendants, Alvogen and DRL Defendants (separate disclosure sent to each defendant group) filed by Novo Nordisk A/S, Novo Nordisk Inc..(Murray, Travis)
February 9, 2023 Filing 102 NOTICE OF SERVICE of Plaintiffs' Second Supplemental Disclosure of Asserted Patents and Claims as to Zydus Defendants filed by Novo Nordisk A/S, Novo Nordisk Inc..(Murray, Travis)
February 9, 2023 Filing 101 NOTICE OF SERVICE of Plaintiffs' First Supplemental Disclosure of Asserted Patents and Claims as to MPI filed by Novo Nordisk A/S, Novo Nordisk Inc..(Murray, Travis)
February 8, 2023 Opinion or Order ORAL ORDER: Due to a conflict on the Court's calendar, the Markman Hearing is rescheduled for 7/13/2023 at 09:00 AM in Courtroom 4B before Judge Colm F. Connolly. Ordered by Judge Colm F. Connolly on 2/8/2023. Associated Cases: 1:22-md-03038-CFC et al.(nmf)
February 3, 2023 Filing 100 MOTION for Claim Construction re (75 in 1:22-cv-01040-CFC, 123 in 1:22-cv-00294-CFC, 98 in 1:22-md-03038-CFC) Claim Construction Chart - filed by Mylan Pharmaceuticals Inc.. (Stamoulis, Stamatios)
February 3, 2023 Filing 99 MOTION for Claim Construction re (75 in 1:22-cv-01040-CFC, 123 in 1:22-cv-00294-CFC, 98 in 1:22-md-03038-CFC) Claim Construction Chart - filed by Novo Nordisk A/S, Novo Nordisk Inc.. (Murray, Travis)
February 3, 2023 Filing 98 CLAIM Construction Chart by Novo Nordisk A/S, Novo Nordisk Inc.. (Attachments: #1 Ex A - '383 Patent, #2 Ex B - '154 Patent, #3 Ex C - '953 Patent, #4 Ex D - '462 Patent)(Murray, Travis)
February 2, 2023 Opinion or Order Filing 97 SO ORDERED, re (73 in 1:22-cv-01040-CFC, 96 in 1:22-md-03038-CFC, 121 in 1:22-cv-00294-CFC) STIPULATION TO EXTEND TIME for Certain Claim Construction Deadlines to Various Dates, filed by Novo Nordisk A/S, Novo Nordisk Inc. Reset Deadlines for Claim Construction Briefing and Markman Hearing: Joint Claim Construction Chart due by 2/3/2023. Claim Construction Opening Brief due by 2/24/2023. Claim Construction Answering Brief due by 3/17/2023. Claim Construction Reply Brief due by 4/6/2023. Claim Construction Surreply Brief due by 4/26/2023. Signed by Judge Colm F. Connolly on 2/2/2023. Associated Cases: 1:22-md-03038-CFC, 1:22-cv-00294-CFC, 1:22-cv-01040-CFC(kmd)
February 1, 2023 Filing 96 STIPULATION TO EXTEND TIME for Certain Claim Construction Deadlines to Various Dates - filed by Novo Nordisk A/S, Novo Nordisk Inc.. (Murray, Travis)
January 31, 2023 Filing 95 REDACTED VERSION of (116 in 1:22-cv-00294-CFC, 90 in 1:22-md-03038-CFC) Stipulation of Dismissal, by Zydus Lifesciences Limited, Zydus Pharmaceuticals (USA) Inc., Zydus Worldwide DMCC. (Kraman, Pilar)
January 31, 2023 Filing 94 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Novo Nordisk Commercial Holdings, Inc., Other Affiliate Novo Nordisk A/S, Other Affiliate Novo Nordisk US Holdings Inc. for Novo Nordisk Inc.; Corporate Parent Novo Holdings A/S, Other Affiliate Novo Nordisk Foundation for Novo Nordisk A/S filed by Novo Nordisk A/S, Novo Nordisk Inc.. (Murray, Travis)
January 27, 2023 Filing 93 NOTICE OF SERVICE of Plaintiffs' Notice to Sun of Subpoena for Production of Documents (confidential as to Sun Pharmaceutical Industries Ltd. And Sun Pharmaceutical Industries, Inc.) filed by Novo Nordisk A/S, Novo Nordisk Inc..(Murray, Travis)
January 27, 2023 Filing 92 NOTICE OF SERVICE of Plaintiffs' Notice to Mylan of Subpoena for Production of Documents (confidential as to Mylan Pharmaceuticals Inc.) filed by Novo Nordisk A/S, Novo Nordisk Inc..(Murray, Travis)
January 27, 2023 Opinion or Order Filing 91 [SEALED] SO ORDERED, re (116 in 1:22-cv-00294-CFC, 90 in 1:22-md-03038-CFC) Stipulation of Dismissal as to Zydus Worldwide DMCC, Zydus Pharmaceuticals (USA) Inc., and Zydus Lifesciences Limited regarding the '383, '239, '154, '611, '953, '155, '063, and '363 Patents, filed by Zydus Worldwide DMCC, Zydus Pharmaceuticals (USA) Inc., Zydus Lifesciences Limited. Signed by Judge Colm F. Connolly on 1/27/2023.This order has been emailed to local counsel. Associated Cases: 1:22-cv-00294-CFC, 1:22-md-03038-CFC(kmd)
January 26, 2023 Filing 90 [SEALED] STIPULATION of Dismissal as to Zydus Worldwide DMCC, Zydus Pharmaceuticals (USA) Inc., and Zydus Lifesciences Limited regarding the '383, '239, '154, '611, '953, '155, '063, and '363 Patents by Zydus Lifesciences Limited, Zydus Pharmaceuticals (USA) Inc., Zydus Worldwide DMCC. (Kraman, Pilar)
January 25, 2023 Filing 89 NOTICE OF SERVICE of Plaintiffs' Proposed Claim Constructions - filed by Novo Nordisk A/S, Novo Nordisk Inc..(Murray, Travis)
January 24, 2023 Filing 88 NOTICE OF SERVICE of Defendants Proposed Constructions and Intrinsic Evidence (with Exhibit A) filed by Dr. Reddy's Laboratories Inc., Dr. Reddy's Laboratories Ltd..(Gattuso, Dominick)
January 23, 2023 Filing 87 NOTICE OF SERVICE of (1) Defendant Mylan Pharmaceuticals Inc.s Objections and Responses to Plaintiffs Third Set of Requests for the Production of Documents and Things (Nos. 163-168) and (2) Defendant Mylan Pharmaceuticals Inc.s Objections and Responses to Third Set of Collective Interrogatories (No 14) filed by Mylan Pharmaceuticals Inc..(Stamoulis, Stamatios)
January 23, 2023 Filing 86 NOTICE OF SERVICE of 1. Alvogen's Responses and Objections to Plaintiffs' Third Set of Requests for the Production of Documents and Things (Nos. 89-94) 2. Alvogen's Responses and Objections to Plaintiffs' Third Set of Collective Interrogatories (No. 14) filed by Alvogen, Inc..(Keller, Karen)
January 23, 2023 Filing 85 NOTICE OF SERVICE of (1) Sun's Responses and Objections to Plaintiffs' Third Set of Collective Interrogatories (No. 14) and (2) Sun's Responses and Objections to Plaintiffs' Third Set of Requests for the Production of Documents and Things (Nos. 77-82) filed by Sun Pharmaceutical Industries Ltd., Sun Pharmaceuticals Industries Inc., Sun Pharmaceutical Industries Inc..(Metzler, Sara)
January 23, 2023 Filing 84 NOTICE OF SERVICE of (i) DRL's Objections and Responses to Plaintiffs' Third Set of Collective Interrogatories to Defendants (No. 14); and, (ii) DRL's Responses and Objections to Plaintiffs' Second Set of Requests for the Production of Documents and Things (Nos. 95-100) filed by Dr. Reddy's Laboratories Ltd., Dr. Reddy's Laboratories Inc..(Gattuso, Dominick)
January 23, 2023 Filing 83 NOTICE OF SERVICE of 1) Defendants Zydus Worldwide DMCC, Zydus Pharmaceuticals (USA) Inc., and Zydus Lifesciences Limited's Objections and Responses to Plaintiffs' Third Set of Collective Interrogatories to Defendants (No. 14); and 2) Defendants Zydus Worldwide DMCC, Zydus Pharmaceuticals (USA) Inc., and Zydus Lifesciences Limited's Objections and Responses to Plaintiffs' Third Set of Requests for the Production of Documents and Things (Nos. 74-91) filed by Zydus Lifesciences Limited, Zydus Pharmaceuticals (USA) Inc., Zydus Worldwide DMCC.(Kraman, Pilar)
January 23, 2023 Filing 82 NOTICE OF SERVICE of (1) Defendants Rio Biopharmaceuticals Inc. and EMS S/A's response to Plaintiffs' Third Set of Collective Interrogatories (No. 14); and (2) Defendants Rio Biopharmaceuticals Inc. and EMS S/A's response to Plaintiffs' Third Set of Requests for Production (Nos. 93-98) filed by EMS S/A, Rio Biopharmaceuticals, Inc..(Dorsney, Kenneth)
January 19, 2023 Filing 81 NOTICE OF SERVICE of Plaintiffs' Identification of Inventors Employed by Plaintiffs and/or Represented by Counsel for Plaintiffs - filed by Novo Nordisk A/S, Novo Nordisk Inc..(Murray, Travis)
January 13, 2023 Filing 80 NOTICE OF SERVICE of Defendants' List of Proposed Terms for Construction filed by Dr. Reddy's Laboratories Ltd., Dr. Reddy's Laboratories Inc..(Gattuso, Dominick)
January 12, 2023 Filing 79 NOTICE OF SERVICE of Plaintiffs' Preliminary Identification of Claim Terms Requiring Construction Pursuant to Paragraph 19 of the Scheduling Order (C.A. No. 22-294-CFC at D.I. 22; C.A. No. 22-1040-CFC at D.I. 53) - filed by Novo Nordisk A/S, Novo Nordisk Inc..(Murray, Travis)
January 4, 2023 Opinion or Order Filing 78 SO ORDERED, re (77 in 1:22-md-03038-CFC, 64 in 1:22-cv-01040-CFC, 104 in 1:22-cv-00294-CFC) Stipulation to Extend Certain Claim Construction Deadlines, filed by Novo Nordisk A/S, Novo Nordisk Inc. Signed by Judge Colm F. Connolly on 1/4/2023. Associated Cases: 1:22-cv-01040-CFC, 1:22-cv-00294-CFC, 1:22-md-03038-CFC(kmd)
January 4, 2023 Filing 77 STIPULATION and [Proposed] Order to Extend Certain Claim Construction Deadlines - by Novo Nordisk A/S, Novo Nordisk Inc.. (Murray, Travis)
December 22, 2022 Filing 76 NOTICE OF SERVICE of Plaintiffs' Third Set of Requests for the Production of Documents and Things (Individual Requests Served on Each Defendant Group) filed by Novo Nordisk A/S, Novo Nordisk Inc..(Murray, Travis)
December 22, 2022 Filing 75 NOTICE OF SERVICE of Plaintiffs' Third Set of Collective Interrogatories to Defendants (No. 14) filed by Novo Nordisk A/S, Novo Nordisk Inc..(Murray, Travis)
December 22, 2022 Filing 74 NOTICE OF SERVICE of Plaintiffs' Third Set of Requests for the Production of Documents and Things (Nos. 163-168) Directed to Defendant Mylan Pharmaceuticals, Inc. filed by Novo Nordisk A/S, Novo Nordisk Inc..(Murray, Travis)
December 21, 2022 Filing 73 NOTICE OF SERVICE of Novo Nordisk's Initial Responses to Defendants' Initial Invalidity Contentions Regarding U.S. Patent Nos. 8,129,343; 8,536,122; 8,114,833; 8,920,383; 9,775,953; 9,457,154; and 10,335,462 filed by Novo Nordisk A/S, Novo Nordisk Inc..(Murray, Travis)
December 16, 2022 Filing 72 NOTICE OF SERVICE of Defendant Mylan Pharmaceuticals Inc.s Objections and Responses to Second Set of Collective Interrogatories (No. 13) filed by Mylan Pharmaceuticals Inc..(Stamoulis, Stamatios)
December 16, 2022 Filing 71 NOTICE OF SERVICE of Plaintiffs' Initial Infringement Contentions (Individual Sets Served on Each Defendant Group) filed by Novo Nordisk A/S, Novo Nordisk Inc..(Egan, Brian)
December 16, 2022 Filing 70 NOTICE OF SERVICE of Defendants Zydus Worldwide DMCC, Zydus Pharmaceuticals (USA) Inc., and Zydus Lifesciences Limited's Objections and Responses to Plaintiffs Second Set of Collective Interrogatories to Defendants (No. 13) filed by Zydus Lifesciences Limited, Zydus Pharmaceuticals (USA) Inc., Zydus Worldwide DMCC.(Kraman, Pilar)
December 16, 2022 Filing 69 NOTICE OF SERVICE of Alvogen's Responses and Objections to Plaintiffs' Second Set of Collective Interrogatories to Defendants (No. 13) filed by Alvogen, Inc..(Keller, Karen)
December 16, 2022 Filing 68 NOTICE OF SERVICE of Suns Responses and Objections to Plaintiffs Second Set of Collective Interrogatories (No. 13) filed by Sun Pharmaceutical Industries Ltd., Sun Pharmaceuticals Industries Inc., Sun Pharmaceutical Industries Inc..(Metzler, Sara)
December 16, 2022 Filing 67 NOTICE OF SERVICE of Defendants Rio Biopharmaceuticals Inc. and EMS S/A's responses to Plaintiff's Second Set of Collective Interrogatories (No. 13) filed by EMS S/A, Rio Biopharmaceuticals, Inc..(Dorsney, Kenneth)
December 15, 2022 Filing 66 NOTICE OF SERVICE of DRL's Objections and Responses to Plaintiffs' Second Set of Collective Interrogatories to Defendants (No. 13) filed by Dr. Reddy's Laboratories Inc., Dr. Reddy's Laboratories Ltd..(Gattuso, Dominick)
December 8, 2022 Filing 65 NOTICE of Appearance by Alexis Stombaugh on behalf of Zydus Lifesciences Limited, Zydus Pharmaceuticals (USA) Inc., Zydus Worldwide DMCC (Stombaugh, Alexis)
December 1, 2022 Filing 64 NOTICE OF SERVICE of Plaintiffs' First Supplemental Disclosure of Asserted Patents and Claims as to Zydus Defendants - filed by Novo Nordisk A/S, Novo Nordisk Inc..(Murray, Travis)
November 30, 2022 Filing 63 NOTICE OF SERVICE of Defendant Mylan Pharmaceuticals Inc.s First Supplemental Objections and Responses to Plaintiffs First Set of Requests for the Production of Documents and Things (Nos. 1-10) filed by Mylan Pharmaceuticals Inc..(Stamoulis, Stamatios)
November 22, 2022 Filing 62 NOTICE OF SERVICE of (1) Plaintiffs' Response to Defendants' First Set of Interrogatories (Nos. 1-4); and (2) Plaintiffs' Response to Defendants' First Set of Requests for Production (Nos. 1-23) filed by Novo Nordisk A/S, Novo Nordisk Inc..(Murray, Travis)
November 21, 2022 Filing 61 REDACTED VERSION of (87 in 1:22-cv-00294-CFC, 57 in 1:22-md-03038-CFC) Stipulation of Dismissal by Novo Nordisk A/S, Novo Nordisk Inc.. (Murray, Travis)
November 18, 2022 Filing 60 NOTICE OF SERVICE of Defendants' Identification of Prior Art to Supplement Defendants' Initial Invalidity Contentions filed by Dr. Reddy's Laboratories Inc., Dr. Reddy's Laboratories Ltd..(Gattuso, Dominick)
November 16, 2022 Filing 59 NOTICE OF SERVICE of Plaintiffs' Second Set of Collective Interrogatories to Defendants (No. 13) filed by Novo Nordisk A/S, Novo Nordisk Inc..(Murray, Travis)
November 16, 2022 Remark: Docket text of Order (87 in 1:22-cv-00294-CFC, 57 in 1:22-md-03038-CFC) corrected. Party Alvogen, Inc. and attorneys reinstated in cases. Associated Cases: 1:22-md-03038-CFC, 1:22-cv-00294-CFC(kmd)
November 15, 2022 Opinion or Order Filing 58 [SEALED] SO ORDERED, re (87 in 1:22-cv-00294-CFC, 57 in 1:22-md-03038-CFC) Stipulation of Dismissal as to Alvogen, Inc. Regarding the '239, '611, '155, '063, and '363 Patents (Joint), filed by Novo Nordisk A/S, Novo Nordisk Inc. Signed by Judge Colm F. Connolly on 11/15/2022.This order has been emailed to local counsel. Associated Cases: 1:22-md-03038-CFC, 1:22-cv-00294-CFC(kmd) Modified on 11/16/2022 (kmd).
November 14, 2022 Filing 57 [SEALED] STIPULATION of Dismissal as to Alvogen, Inc. Regarding the '239, '611, '155, '063, and '363 Patents (Joint) by Novo Nordisk A/S, Novo Nordisk Inc.. (Murray, Travis)
November 10, 2022 Filing 56 NOTICE OF SERVICE of Defendant Mylan Pharmaceuticals Inc.s Objections and Responses to First Set of Collective Interrogatories (Nos. 1-12) filed by Mylan Pharmaceuticals Inc..(Stamoulis, Stamatios)
November 9, 2022 Opinion or Order Filing 55 SO ORDERED, re (52 in 1:22-cv-01040-CFC, 52 in 1:22-md-03038-CFC) PROPOSED ORDER Adopting Scheduling Order, Protective Order and ESI Order. Signed by Judge Colm F. Connolly on 11/9/2022. (nmf)
November 8, 2022 Filing 54 NOTICE OF SERVICE of (1) Plaintiffs' First Amended Disclosures Under Paragraph 3 of the District of Delaware Default Standard to the Sun Defendants and (2) Plaintiffs' First Amended Disclosures Pursuant to Rule 26(a)(1) of the Federal Rules of Civil Procedure to the Sun Defendants - filed by Novo Nordisk A/S, Novo Nordisk Inc..(Murray, Travis)
November 8, 2022 Filing 53 NOTICE OF SERVICE of (1) Plaintiffs' First Amended Disclosures to Defendants Zydus Worldwide DMCC, Zydus Pharmaceuticals (USA) Inc., and Zydus Lifesciences Limited Pursuant to Rule 26(a)(1) of the Federal Rules of Civil Procedure and (2) Plaintiffs' First Amended Disclosures to Defendants Zydus Worldwide DMCC, Zydus Pharmaceuticals (USA) Inc., and Zydus Lifesciences Limited Under Paragraph 3 of the District of Delaware Default Standard - filed by Novo Nordisk A/S, Novo Nordisk Inc..(Murray, Travis)
November 4, 2022 Filing 52 PROPOSED ORDER Adopting Scheduling Order, Protective Order and ESI Order by Novo Nordisk A/S, Novo Nordisk Inc.. (Egan, Brian)
November 3, 2022 Filing 51 NOTICE OF SERVICE of Defendants Zydus Worldwide DMCC, Zydus Pharmaceuticals (USA) Inc., and Zydus Lifesciences Limited's Objections and Responses to Plaintiffs' Second Set of Requests for the Production of Documents and Things (Nos. 11-73) filed by Zydus Lifesciences Limited, Zydus Pharmaceuticals (USA) Inc., Zydus Worldwide DMCC.(Kraman, Pilar)
October 27, 2022 Filing 50 NOTICE OF SERVICE of Defendant Mylan Pharmaceuticals Inc.s Objections and Responses to Plaintiffs Second Set of Requests for the Production of Documents and Things (Nos. 11-162) filed by Mylan Pharmaceuticals Inc..(Stamoulis, Stamatios)
October 27, 2022 Filing 49 NOTICE OF SERVICE of Defendant's Responses and Objections to Plaintiffs' Second Set of Requests for the Production of Documents and Things (Nos. 11 - 88) filed by Alvogen, Inc..(Hoeschen, Nathan)
October 27, 2022 Filing 48 NOTICE OF SERVICE of DRL's Responses and Objections to Plaintiffs' Second Set of Requests for the Production of Documents and Things (Nos. 11-94) filed by Dr. Reddy's Laboratories Inc., Dr. Reddy's Laboratories Ltd..(Gattuso, Dominick)
October 27, 2022 Filing 47 NOTICE OF SERVICE of Suns Responses and Objections to Plaintiffs Second Set of Requests for the Production of Documents and Things (Nos. 11-76) filed by Sun Pharmaceutical Industries Ltd., Sun Pharmaceuticals Industries Inc., Sun Pharmaceutical Industries Inc..(Farnan, Kelly)
October 27, 2022 Filing 46 NOTICE OF SERVICE of DEFENDANTS RIO BIOPHARMACEUTICALS INC. AND EMS S/AS OBJECTIONS AND RESPONSES TO PLAINTIFFS SECOND SET OF REQUESTS FOR PRODUCTION OF DOCUMENTS (NOS. 11-92) filed by EMS S/A, Rio Biopharmaceuticals, Inc..(Hitch, Cortlan)
October 21, 2022 Filing 45 NOTICE OF SERVICE of Defendants First Set of Interrogatories to Plaintiffs and Defendants First Set of Requests for Production to Plaintiffs filed by Mylan Pharmaceuticals Inc..(Stamoulis, Stamatios)
October 21, 2022 Opinion or Order SO ORDERED, re (78 in 1:22-cv-00294-CFC, 42 in 1:22-md-03038-CFC) MOTION for Pro Hac Vice Appearance of Attorney Aaron Z. Savit, filed by Alvogen, Inc. Ordered by Judge Colm F. Connolly on 10/21/2022. Associated Cases: 1:22-cv-00294-CFC, 1:22-md-03038-CFC(kmd)
October 21, 2022 Pro Hac Vice Attorney Aaron Z. Savit for Alvogen, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mpb)
October 20, 2022 Filing 44 NOTICE OF SERVICE of Defendants Noninfringement Contentions filed by Mylan Pharmaceuticals Inc..(Stamoulis, Stamatios)
October 20, 2022 Filing 43 NOTICE OF SERVICE of Initial Invalidity Contentions filed by Sun Pharmaceutical Industries Inc., Sun Pharmaceutical Industries Ltd..(Metzler, Sara)
October 20, 2022 Filing 42 MOTION for Pro Hac Vice Appearance of Attorney Aaron Z. Savit - filed by Alvogen, Inc.. (Hoeschen, Nathan)
October 20, 2022 Filing 41 NOTICE OF SERVICE of Alvogen, Inc.'s Preliminary Non-Infringement Contentions filed by Alvogen, Inc..(Hoeschen, Nathan)
October 20, 2022 Filing 40 NOTICE OF SERVICE of Sun's Initial Non-Infringement Contentions filed by Sun Pharmaceutical Industries Ltd., Sun Pharmaceuticals Industries Inc., Sun Pharmaceutical Industries Inc..(Farnan, Kelly)
October 20, 2022 Filing 39 NOTICE OF SERVICE of copy of DRL's Noninfringement Contentions [CONFIDENTIAL] filed by Dr. Reddy's Laboratories Inc., Dr. Reddy's Laboratories Ltd..(Gattuso, Dominick)
October 20, 2022 Filing 38 NOTICE OF SERVICE of Defendants Zydus Worldwide DMCC, Zydus Pharmaceuticals (USA) Inc., and Zydus Lifesciences Limited's Initial Noninfringement Contentions filed by Zydus Lifesciences Limited, Zydus Pharmaceuticals (USA) Inc., Zydus Worldwide DMCC.(Kraman, Pilar)
October 20, 2022 Filing 37 NOTICE OF SERVICE of Defendants Rio Biopharmaceuticals Inc. and EMS S/A's Noninfringement Contentions Regarding Claims 12-14 of the '154 Patent filed by EMS S/A, Rio Biopharmaceuticals, Inc..(Dorsney, Kenneth)
October 20, 2022 Opinion or Order Filing 36 [SEALED] SO ORDERED, re (70 in 1:22-cv-00294-CFC, 34 in 1:22-md-03038-CFC) Stipulation of Dismissal as to Rio Biopharmaceuticals Inc. and EMS S/A Regarding the '239 and '611 Patents, filed by Novo Nordisk A/S, Novo Nordisk Inc. Signed by Judge Colm F. Connolly on 10/20/2022.This order has been emailed to local counsel. Associated Cases: 1:22-md-03038-CFC, 1:22-cv-00294-CFC(kmd)
October 19, 2022 Filing 35 REDACTED VERSION of (70 in 1:22-cv-00294-CFC, 34 in 1:22-md-03038-CFC) Stipulation - by Novo Nordisk A/S, Novo Nordisk Inc.. (Murray, Travis)
October 19, 2022 Filing 34 [SEALED] STIPULATION and [Proposed] Order of Dismissal as to Rio Biopharmaceuticals Inc. and EMS S/A Regarding the '239 and '611 Patents - by Novo Nordisk A/S, Novo Nordisk Inc.. (Murray, Travis)
October 14, 2022 Filing 33 NOTICE of Withdrawal of Joshua S. Reisberg by Alvogen, Inc. (Keller, Karen)
October 13, 2022 Filing 32 ANSWER to Amended Complaint, re: #25 Amended Complaint by Zydus Lifesciences Limited, Zydus Pharmaceuticals (USA) Inc., Zydus Worldwide DMCC.(Kraman, Pilar)
October 11, 2022 Filing 31 NOTICE OF SERVICE of Plaintiffs' First Set of Collective Interrogatories to Defendants (Nos. 1-12) - filed by Novo Nordisk A/S, Novo Nordisk Inc..(Murray, Travis)
October 7, 2022 Filing 30 NOTICE OF SERVICE of Defendants Rio Biopharmaceuticals Inc. and EMS S/A's responses to Plaintiff's First Set of Collective Interrogatories (Nos. 1-12) filed by EMS S/A, Rio Biopharmaceuticals, Inc..(Dorsney, Kenneth)
October 7, 2022 Filing 29 NOTICE OF SERVICE of Defendants Responses to Plaintiffs First Set of Collective Interrogatories (Nos. 1-12) filed by Alvogen, Inc..(Keller, Karen)
October 7, 2022 Filing 28 NOTICE OF SERVICE of DRL's Objections and Responses to Plaintiffs' First Set of Collective Interrogatories to Defendants (Nos. 1-12) filed by Dr. Reddy's Laboratories Inc..(Gattuso, Dominick)
October 7, 2022 Filing 27 NOTICE OF SERVICE of Suns Responses and Objections to Plaintiffs First Set of Collective Interrogatories to Defendants (Nos. 1-12) filed by Sun Pharmaceutical Industries Ltd., Sun Pharmaceuticals Industries Inc., Sun Pharmaceutical Industries Inc..(Farnan, Kelly)
October 7, 2022 Filing 26 NOTICE OF SERVICE of Defendants Zydus Worldwide DMCC, Zydus Pharmaceuticals (USA) Inc., and Zydus Lifesciences Limited's Objections and Responses to Plaintiffs' First Set of Collective Interrogatories to Defendants (Nos. 1-12) filed by Zydus Lifesciences Limited, Zydus Pharmaceuticals (USA) Inc., Zydus Worldwide DMCC.(Kraman, Pilar)
September 29, 2022 Filing 25 FIRST AMENDED COMPLAINT against Zydus Lifesciences Limited, Zydus Pharmaceuticals (USA) Inc., Zydus Worldwide DMCC- filed by Novo Nordisk Inc., Novo Nordisk A/S. (Attachments: #1 Exhibit A-J)(kmd)
September 29, 2022 Opinion or Order Filing 24 ORDER granting ((23) in case 1:22-md-03038-CFC, (61) in case 1:22-cv-00294-CFC) Motion for Leave to File Amended Complaint Against Zydus (Unopposed). Signed by Judge Colm F. Connolly on 9/29/2022. Associated Cases: 1:22-md-03038-CFC, 1:22-cv-00294-CFC(kmd)
September 28, 2022 Filing 23 MOTION for Leave to File Amended Complaint Against Zydus (Unopposed) - filed by Novo Nordisk A/S, Novo Nordisk Inc.. (Attachments: #1 Ex. 1 - First Amended Complaint, #2 Exhibits A-J to First Amended Complaint, #3 Ex. 2 - Redline)(Egan, Brian)
September 28, 2022 Pro Hac Vice Attorney Aziz Burgy for Alvogen, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. Associated Cases: 1:22-md-03038-CFC, 1:22-cv-00294-CFC(mpb)
September 27, 2022 Filing 22 NOTICE OF SERVICE of (1) Plaintiffs' Second Set of Requests for the Production of Documents and Things (Nos. 11-88) Directed to Defendant Alvogen, Inc., (2) Plaintiffs' Second Set of Requests for the Production of Documents and Things (Nos. 11-94) Directed to Defendants Dr. Reddy's Laboratories, Ltd. and Dr. Reddy's Laboratories, Inc., (3) Plaintiffs' Second Set of Requests for the Production of Documents and Things (Nos. 11-92) Directed to Defendants Rio Biopharmaceuticals Inc. and EMS S/A, (4) Plaintiffs' Second Set of Requests for the Production of Documents and Things (Nos. 11-76) Directed to Defendants Sun Pharmaceutical Industries Ltd. and Sun Pharmaceutical Industries, Inc., and (5) Plaintiffs' Second Set of Requests for the Production of Documents and Things (Nos. 11-73) Directed to Defendants Zydus Worldwide DMCC, Zydus Pharmaceuticals (USA) Inc., and Zydus Lifesciences Limited - filed by Novo Nordisk A/S, Novo Nordisk Inc..(Murray, Travis)
September 27, 2022 Filing 21 NOTICE OF SERVICE of Plaintiffs' Second Set of Requests for the Production of Documents and Things (Nos. 11-162) Directed to Defendant Mylan Pharmaceuticals, Inc. - filed by Novo Nordisk A/S, Novo Nordisk Inc..(Murray, Travis)
September 27, 2022 Filing 20 MOTION for Pro Hac Vice Appearance of Attorney Aziz Burgy - filed by Alvogen, Inc.. (Keller, Karen)
September 27, 2022 Opinion or Order SO ORDERED, re (59 in 1:22-cv-00294-CFC, 20 in 1:22-md-03038-CFC) MOTION for Pro Hac Vice Appearance of Attorney Aziz Burgy, filed by Alvogen, Inc. Ordered by Judge Colm F. Connolly on 9/27/2022. Associated Cases: 1:22-cv-00294-CFC, 1:22-md-03038-CFC(kmd)
September 9, 2022 Filing 19 NOTICE OF SERVICE of Defendant Mylan Pharmaceuticals Inc.s Objections and Responses to Plaintiffs First Set of Requests for the Production of Documents and Things (Nos. 1-10) filed by Mylan Pharmaceuticals Inc..(Stamoulis, Stamatios)
September 7, 2022 Filing 18 NOTICE OF SERVICE of Plaintiffs' First Set of Collective Interrogatories to Defendants (Nos. 1-12) - filed by Novo Nordisk A/S, Novo Nordisk Inc..(Murray, Travis)
September 7, 2022 Pro Hac Vice Attorney Shannon M. Bloodworth for Mylan Pharmaceuticals Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (apk)
September 7, 2022 Pro Hac Vice Attorney Bryan D. Beel for Mylan Pharmaceuticals Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (apk)
August 30, 2022 Opinion or Order SO ORDERED, re (17 in 1:22-md-03038-CFC, 44 in 1:22-cv-01040-CFC) MOTION for Pro Hac Vice Appearance of Attorney Jonathan I. Tietz, Shannon M. Bloodworth, Emily J. Greb, Michael R. Laing, and Bryan D. Beel, Ph.D., filed by Mylan Pharmaceuticals Inc. Ordered by Judge Colm F. Connolly on 8/30/2022. Associated Cases: 1:22-md-03038-CFC, 1:22-cv-01040-CFC(kmd)
August 29, 2022 Filing 17 MOTION for Pro Hac Vice Appearance of Attorney Jonathan I. Tietz, Shannon M. Bloodworth, Emily J. Greb, Michael R. Laing, and Bryan D. Beel, Ph.D. - filed by Mylan Pharmaceuticals Inc.. (Stamoulis, Stamatios)
August 26, 2022 Filing 16 NOTICE OF SERVICE of Defendant Mylan Pharmaceuticals Inc.s Initial Disclosures Pursuant to the Delaware Default Standard for Discovery filed by Mylan Pharmaceuticals Inc..(Stamoulis, Stamatios)
August 26, 2022 Filing 15 NOTICE OF SERVICE of Plaintiffs' Preliminary Disclosure of Asserted Patents and Claims filed by Novo Nordisk A/S, Novo Nordisk Inc..(Egan, Brian)
August 26, 2022 Filing 14 NOTICE OF SERVICE of (1) Plaintiffs' Disclosures Under Paragraph 3 of the District of Delaware Default Standard; and (2) Plaintiffs' Preliminary Disclosure of Asserted Patents and Claims filed by Novo Nordisk A/S, Novo Nordisk Inc..(Egan, Brian)
August 25, 2022 Filing 13 NOTICE of Appearance by Richard Charles Weinblatt on behalf of Mylan Pharmaceuticals Inc. (Weinblatt, Richard)
August 25, 2022 Filing 12 NOTICE of Appearance by Stamatios Stamoulis on behalf of Mylan Pharmaceuticals Inc. (Stamoulis, Stamatios)
August 22, 2022 Filing 11 MOTION for Pro Hac Vice Appearance of Attorney Jeffrey J. Oelke, Ryan P. Johnson, Robert E. Counihan, Laura T. Moran, Erica R. Sutter and Olivia L. Wheeling - filed by Novo Nordisk A/S, Novo Nordisk Inc.. (Egan, Brian)
August 22, 2022 Opinion or Order SO ORDERED, re (39 in 1:22-cv-01040-CFC, 11 in 1:22-md-03038-CFC) MOTION for Pro Hac Vice Appearance of Attorney Jeffrey J. Oelke, Ryan P. Johnson, Robert E. Counihan, Laura T. Moran, Erica R. Sutter and Olivia L. Wheeling, filed by Novo Nordisk A/S, Novo Nordisk Inc. Ordered by Judge Colm F. Connolly on 8/22/2022. Associated Cases: 1:22-md-03038-CFC, 1:22-cv-01040-CFC(kmd)
August 19, 2022 Filing 10 ANSWER to Complaint / Counterclaims -- Plaintiffs' Answer to Sun Pharmaceutical Industries Ltd. and Sun Pharmaceutical Industries Inc.'s Counterclaims -- by Novo Nordisk A/S, Novo Nordisk Inc..(Egan, Brian)
August 12, 2022 Filing 9 NOTICE OF SERVICE of Plaintiffs' Amended Disclosures Pursuant to Rule 26(a)(1) of the Federal Rules of Civil Procedure - filed by Novo Nordisk A/S, Novo Nordisk Inc..(Murray, Travis)
August 11, 2022 Filing 8 NOTICE OF SERVICE of Defendant's Objections and Responses to Plaintiffs' First Set of Requests for the Production of Documents and Things (Nos. 1-10) filed by Alvogen, Inc..(Hoeschen, Nathan)
August 11, 2022 Filing 7 NOTICE OF SERVICE of Defendants Zydus Worldwide DMCC, Zydus Pharmaceuticals (USA) Inc., and Zydus Lifesciences Limited's Objections and Responses to Plaintiffs' First Set of Requests for the Production of Documents and Things (Nos. 1-10) filed by Zydus Lifesciences Limited, Zydus Pharmaceuticals (USA) Inc., Zydus Worldwide DMCC.(Kraman, Pilar)
August 10, 2022 Filing 6 NOTICE OF SERVICE of Plaintiffs' First Set of Requests for the Production of Documents and Things (Nos. 1-10) filed by Novo Nordisk A/S, Novo Nordisk Inc..(Murray, Travis)
August 10, 2022 Filing 5 NOTICE OF SERVICE of DRL's Responses and Objections to Plaintiffs' First Requests for the Production of Documents and Things (Nos. 1-10) Directed to DRL filed by Dr. Reddy's Laboratories Inc., Dr. Reddy's Laboratories Ltd..(Gattuso, Dominick)
August 10, 2022 Filing 4 NOTICE OF SERVICE of Defendants Rio Biopharmaceuticals Inc. and EMS S/A's responses to Plaintiff's First Set of Requests for Production (Nos. 1-10) filed by EMS S/A, Rio Biopharmaceuticals, Inc..(Dorsney, Kenneth)
August 8, 2022 Filing 3 NOTICE of Appearance by Brian P. Egan on behalf of Novo Nordisk A/S, Novo Nordisk Inc. (Egan, Brian)
August 5, 2022 Filing 2 Letter to Clerk, USDC/NDWV from Clerk, USDC/DE, dated 08/05/2022, regarding transfer of Civil Action to Delaware. (smg)
August 5, 2022 Filing 1 CERTIFIED TRANSFER ORDER - issued by the Panel on Multi-District Litigation on 08/05/2022 - Associated DE Cases: CA 22-cv-294-CFC, CA 22-cv-296-CFC, CA 22-cv-297-CFC, CA 22-cv-298-CFC, CA 22-cv-299-CFC. (smg)
August 5, 2022 NOTICE TO COUNSEL: MDL No. 1:2022-md-3038 has been opened and assigned to the Honorable Colm F. Connolly. Attorneys of record who will be electronically filing documents may request E-Filing rights through PACER and add the MDL case number in the comments section of your request. Please see the docket for further entries. Associated Cases: 1:22-md-03038-CFC et al.(smg)
August 5, 2022 The following cases in the District of Delaware are included in this MDL: 1:22-cv-00294-CFC, 1:22-cv-00296-CFC, 1:22-cv-00297-CFC, 1:22-cv-00298-CFC, 1:22-cv-00299-CFC. (smg)
August 5, 2022 NOTICE: Documents relating to all actions should be filed on the master docket sheet and on the docket sheet of each individual action. Documents relating to two or more, but not all, individual actions should be filed on the master docket sheet, and on the docket sheet of each affected individual action. Documents affecting a single individual action should be filed on the docket sheet of that action and on the master docket sheet. Associated Cases: 1:22-md-03038-CFC, 1:22-cv-00294-CFC, 1:22-cv-00296-CFC, 1:22-cv-00297-CFC, 1:22-cv-00298-CFC, 1:22-cv-00299-CFC.(smg)

Access additional case information on PACER

Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.

Access this case on the Delaware District Court's Electronic Court Filings (ECF) System

Search for this case: In Re: Ozempic (Semaglutide) Patent Litigation
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Web [ Unicourt | Legal Web | Google | Bing | Yahoo | Ask ]
Not classified by court: Zydus Lifesciences Limited
Represented By: Pilar Gabrielle Kraman
Represented By: August M. Melcher
Represented By: Carolyn A. Blessing
Represented By: David B. Abramowitz
Represented By: Jacob C. Britz
Represented By: Michael J. Gaertner
Represented By: Alexis Stombaugh
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Not classified by court: Ozempic (Semaglutide) Patent Litigation
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Not classified by court: Novo Nordisk Inc.
Represented By: Jack B. Blumenfeld
Represented By: Travis J Murray
Represented By: Brian P. Egan
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Not classified by court: Novo Nordisk A/S
Represented By: Jack B. Blumenfeld
Represented By: Travis J Murray
Represented By: Brian P. Egan
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Not classified by court: Rio Biopharmaceuticals, Inc.
Represented By: Kenneth Laurence Dorsney
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Not classified by court: EMS S/A
Represented By: Kenneth Laurence Dorsney
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Not classified by court: Sun Pharmaceutical Industries Ltd.
Represented By: Kelly E. Farnan
Represented By: Christopher B. Ferenc
Represented By: Christopher W. West
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Not classified by court: Sun Pharmaceuticals Industries Inc.
Represented By: Kelly E. Farnan
Represented By: Christopher B. Ferenc
Represented By: Christopher W. West
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Not classified by court: Clerk of MDL Panel
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Not classified by court: Zydus Worldwide DMCC
Represented By: Pilar Gabrielle Kraman
Represented By: August M. Melcher
Represented By: Carolyn A. Blessing
Represented By: David B. Abramowitz
Represented By: Jacob C. Britz
Represented By: Michael J. Gaertner
Represented By: Alexis Stombaugh
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Not classified by court: Zydus Pharmaceuticals (USA) Inc.
Represented By: Pilar Gabrielle Kraman
Represented By: August M. Melcher
Represented By: Carolyn A. Blessing
Represented By: David B. Abramowitz
Represented By: Jacob C. Britz
Represented By: Michael J. Gaertner
Represented By: Alexis Stombaugh
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Not classified by court: Cadila Healthcare Ltd.
Represented By: Pilar Gabrielle Kraman
Represented By: August M. Melcher
Represented By: Carolyn A. Blessing
Represented By: David B. Abramowitz
Represented By: Jacob C. Britz
Represented By: Michael J. Gaertner
Represented By: Alexis Stombaugh
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Not classified by court: Dr. Reddy's Laboratories Ltd.
Represented By: Dominick T. Gattuso
Represented By: Alison M. King
Represented By: Jovial Wong
Represented By: Sharon Lin
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Not classified by court: Dr. Reddy's Laboratories Inc.
Represented By: Dominick T. Gattuso
Represented By: Alison M. King
Represented By: Jovial Wong
Represented By: Sharon Lin
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Not classified by court: Alvogen, Inc.
Represented By: Karen Elizabeth Keller
Represented By: Chantelle D. Ankerman
Represented By: Emily DiBenedetto
Represented By: Joshua S. Reisberg
Represented By: Matthew J. Becker
Represented By: Aziz Burgy
Represented By: Aaron Z. Savit
Represented By: Nathan Roger Hoeschen
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Not classified by court: Mylan Pharmaceuticals Inc.
Represented By: Gordon H. Copland
Represented By: Brandon M. White
Represented By: William J O'Brien
Represented By: Bryan D. Beel
Represented By: Richard Charles Weinblatt
Represented By: Shannon M. Bloodworth
Represented By: Stamatios Stamoulis
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]

Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.

Why Is My Information Online?